Stay updated on Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.6.2, was added to the Record History and the previous v3.6.0 entry was removed, indicating the study record was updated to reflect a newer version.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study’s history now shows that recruitment has ended and adds a new revision (v3.6.0), while the older revision note (v3.5.5) was removed.SummaryDifference0.3%

- Check22 days agoChange DetectedOn 2026-06-03, results have been posted and the Outcome Measures (Results) section is now populated. The record shows a Study Status update and a new Revision: v3.5.5.SummaryDifference0.6%

- Check44 days agoChange DetectedRevision badge updated from v3.5.3 to v3.5.4 at the bottom of the page. This reflects a new site version and does not change the page content or user interactions.SummaryDifference0.1%

- Check51 days agoChange DetectedRecord History shows new entries and sections added to the study record, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and More Information, plus a Quality Control Review Has Not Concluded status and a Returned date of 2026-05-06.SummaryDifference1%

- Check65 days agoChange DetectedThe ClinicalTrials.gov page footer has been updated to reflect a newer site/release version (v3.5.3 instead of v3.5.2). This represents a maintenance/release update rather than a change to the study record itself.SummaryDifference0.1%

Stay in the know with updates to Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial page.